41
Participants
Start Date
December 17, 2014
Primary Completion Date
December 12, 2016
Study Completion Date
February 15, 2017
Eleclazine
Tablets administered orally
Eleclazine placebo
Tablets administered orally
NYU Langone Medical Center, New York
University of Rochester Medical Center, Rochester
Fondazione Salvatore Maugeri IRCCS, Pavia
L'institut Du Thorax Nantes, Nantes
Mayo Clinic Rochester, Rochester
Groupe Hospitalier Bichat Claude Bernard, Paris
LMU Klinikum der Universität München, München
CHU Réunion Sud, Saint-Pierre
Nova Scotia Health Authority, Halifax
Tel Aviv Sourasky Medical Center, Tel Aviv
Academisch Medisch Centrum Amsterdam, Amsterdam
Barts and The London School of Medicine and Dentistry, London
Lead Sponsor
Gilead Sciences
INDUSTRY